Tags

Type your tag names separated by a space and hit enter

[Chronic venous insufficiency: an open trial of FLEBS Crema].
Minerva Cardioangiol. 2003 Aug; 51(4):411-6.MC

Abstract

AIM

This study was realized to evaluate the FLEBS CREMA tolerability and its therapeutic efficacy, in patients with functional disease linked to not complicated venous or lymphatic insufficiency. This compound acts as vasoconstrictor thanks to the vegetable extract of Ruscus aculeatus, but it is also able to reduce the edema, thanks to the vegetable extract of Melilotus officinalis.

METHODS

All the patients were treated for three weeks with FLEBS CREMA, that was applied 2 or 3 times a day, on both legs. The traditional clinical parameters of chronic venous insufficiency (IVC) (edema, pain, heaviness, itch, cramps and other symptoms) were evaluated during the treatment.

RESULTS

The results show an improvement for all the monitored symptoms, also if the positive clinical response was different for each evaluated parameter. The best results were obtained for edema, pain, heaviness and itch: the statistical analysis shows indeed a significant difference between the beginning and the end of the treatment. In this study the dermo-cosmetic qualities and the tolerability of FLEBS CREMA were also evaluated: both these parameters obtained a positive clinical evaluation.

CONCLUSIONS

Basing on these data, the final evaluation for this compound was good/very good for the 80-90% both doctor and patients.

Authors+Show Affiliations

Docente di Fisiopatologia Chirurgica, Università degli Studi di Catania, Catania, Italy.

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

ita

PubMed ID

12900723

Citation

Consoli, A. "[Chronic Venous Insufficiency: an Open Trial of FLEBS Crema]." Minerva Cardioangiologica, vol. 51, no. 4, 2003, pp. 411-6.
Consoli A. [Chronic venous insufficiency: an open trial of FLEBS Crema]. Minerva Cardioangiol. 2003;51(4):411-6.
Consoli, A. (2003). [Chronic venous insufficiency: an open trial of FLEBS Crema]. Minerva Cardioangiologica, 51(4), 411-6.
Consoli A. [Chronic Venous Insufficiency: an Open Trial of FLEBS Crema]. Minerva Cardioangiol. 2003;51(4):411-6. PubMed PMID: 12900723.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Chronic venous insufficiency: an open trial of FLEBS Crema]. A1 - Consoli,A, PY - 2003/8/6/pubmed PY - 2004/1/24/medline PY - 2003/8/6/entrez SP - 411 EP - 6 JF - Minerva cardioangiologica JO - Minerva Cardioangiol VL - 51 IS - 4 N2 - AIM: This study was realized to evaluate the FLEBS CREMA tolerability and its therapeutic efficacy, in patients with functional disease linked to not complicated venous or lymphatic insufficiency. This compound acts as vasoconstrictor thanks to the vegetable extract of Ruscus aculeatus, but it is also able to reduce the edema, thanks to the vegetable extract of Melilotus officinalis. METHODS: All the patients were treated for three weeks with FLEBS CREMA, that was applied 2 or 3 times a day, on both legs. The traditional clinical parameters of chronic venous insufficiency (IVC) (edema, pain, heaviness, itch, cramps and other symptoms) were evaluated during the treatment. RESULTS: The results show an improvement for all the monitored symptoms, also if the positive clinical response was different for each evaluated parameter. The best results were obtained for edema, pain, heaviness and itch: the statistical analysis shows indeed a significant difference between the beginning and the end of the treatment. In this study the dermo-cosmetic qualities and the tolerability of FLEBS CREMA were also evaluated: both these parameters obtained a positive clinical evaluation. CONCLUSIONS: Basing on these data, the final evaluation for this compound was good/very good for the 80-90% both doctor and patients. SN - 0026-4725 UR - https://www.unboundmedicine.com/medline/citation/12900723/[Chronic_venous_insufficiency:_an_open_trial_of_FLEBS_Crema]_ L2 - https://medlineplus.gov/herbalmedicine.html DB - PRIME DP - Unbound Medicine ER -